Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines
South Korean regulators have revised requirements to significantly reduce the time and financial burden of biosimilar development.
Search results for "AI"
Step Up Your Pace: Four 10-Minute Walking Routines That Maximize Calorie Burn
Walking is one of the most accessible and practical forms of exercise, requiring no specialized equipment or gym memberships.
Samsung Medical Center Launches Specialized Committee to Assess Treatment Fitness in Older Cancer Patients
Even among cancer patients in their 70s, the capacity to tolerate major surgery or aggressive chemotherapy varies...
Ditch the Late-Night Sweets: How Swapping Cookies for Cherries Can Reset Your Sleep Cycle
If you find yourself tossing and turning night after night, the solution might start with a simple adjustment to your...
Chasing the Sea with TWS: A Vibrant Summer Guide to Gangneung’s Thrills, Scenic Views, and Local Flavors
No summer vacation checklist is complete without a trip to the beach. The cool crash of the waves, the crisp ocean...
Swapping Your Afternoon Coffee: Five Summer Teas That Curb Cravings and Beat the Heat
Many office workers reach for an iced coffee out of habit after lunch. However, popular coffee drinks loaded with...
Expired flour? Don’t toss it — try scrubbing ‘this’ with it: 3 unexpected uses
It’s easy to assume flour doesn’t go bad. But if you store it improperly or keep it past its expiration date, its...
The Catharsis Delusion: Why Online Venting Only Fuels South Korea's Cycle of Rage
South Korea is in an angry mood. As one social controversy after another erupts, many people are actively searching for...
Pack More Than a Passport: The Essential Guide to Travel Vaccines and Malaria Prevention
If you have already packed your bags for peak vacation season, it is still too early to completely relax.
Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch
Daewoong Pharmaceutical announced on the 13th that its flagship botulinum toxin product, Nabota, surpassed 1 trillion...